Drug companies are not able to see a physician’s prescribing habits in New Hampshire, according to Tuesday’s ruling in a federal appeals court.
Reps often would have a detailed dossier on the doctor prior to any interaction, and can tailor their pitch and approach based on prescribing trends. It would be interesting to see how they do without that information.
Thanks to the WSJ Health Blog for picking up my Tweet on the subject.
topics: new hampshire, drug reps
Related posts:
- Drug reps getting cranky
- Are drug reps tainting physician food?
- The waiting room: Drug reps add to the tension
- Meet the anti drug reps
- Drug reps seeing the doctor: Battle strategy
- Licensing drug reps
- Are your drug samples spoiled?
 
Follow on Twitter  
Subscribe





Comments on this entry are closed.